These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30459006)

  • 1. Compatibility between a rabies vaccine and a combined vaccine against canine distemper, adenovirosis, parvovirosis, parainfluenza virus and leptospirosis.
    Bouvet J; Cariou C; Poulard A; Oberli F; Cupillard L; Guigal PM
    Vet Immunol Immunopathol; 2018 Nov; 205():93-96. PubMed ID: 30459006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility between a rabies vaccine and two canine combined vaccines against canine distemper, adenovirosis, parvovirosis, parainfluenza virus disease and leptospirosis, with or without canine coronavirus.
    Thibault JC; Bouvet J; Cupillard L; Cariou C; Oberli F
    Comp Immunol Microbiol Infect Dis; 2022 Jul; 86():101803. PubMed ID: 35429805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and serological response of wild dogs (Lycaon pictus) to vaccination against canine distemper, canine parvovirus infection and rabies.
    van Heerden J; Bingham J; van Vuuren M; Burroughs RE; Stylianides E
    J S Afr Vet Assoc; 2002 Mar; 73(1):8-12. PubMed ID: 12088076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate analysis of the immune response to a vaccine as an alternative to the repetition of animal challenge studies for vaccines with demonstrated efficacy.
    Chapat L; Hilaire F; Bouvet J; Pialot D; Philippe-Reversat C; Guiot AL; Remolue L; Lechenet J; Andreoni C; Poulet H; Day MJ; De Luca K; Cariou C; Cupillard L
    Vet Immunol Immunopathol; 2017 Jul; 189():58-65. PubMed ID: 28669388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination at different anatomic sites induces different levels of the immune responses.
    Jin H; Xu Y; Shi F; Hu S
    Res Vet Sci; 2019 Feb; 122():50-55. PubMed ID: 30453180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
    Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
    Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
    Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
    Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroconversion of puppies to canine parvovirus and canine distemper virus: a comparison of two combination vaccines.
    Coyne MJ
    J Am Anim Hosp Assoc; 2000; 36(2):137-42. PubMed ID: 10730624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
    Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
    Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
    Luo J; Shi H; Tan Y; Niu X; Long T; Zhao J; Tian Q; Wang Y; Chen H; Guo X
    Vaccine; 2016 Aug; 34(37):4392-8. PubMed ID: 27449079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of different strategies of multivalent DNA-based vaccination against rabies and canine distemper in mice and dogs.
    Touihri L; Ahmed SB; Chtourou Y; Daoud R; Bahloul C
    Virol J; 2012 Dec; 9():319. PubMed ID: 23270301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to parvovirus, distemper virus and adenovirus conferred to household dogs using commercial combination vaccines containing Leptospira bacterin.
    Taguchi M; Namikawa K; Maruo T; Lynch J; Sahara H
    Vet Rec; 2010 Dec; 167(24):931-4. PubMed ID: 21262693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effectiveness and safety of an immunization against parvovirus and rabies in anesthetized puppies].
    Mayr B; Hönig A; Gutbrod F; Wiedemann C
    Tierarztl Prax; 1990 Apr; 18(2):165-9. PubMed ID: 2161572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine viral vaccines at a turning point--a personal perspective.
    Carmichael LE
    Adv Vet Med; 1999; 41():289-307. PubMed ID: 9890023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
    Larson LJ; Schultz RD
    Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
    Litster A; Nichols J; Volpe A
    Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
    Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
    Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant rabies virus expressing the H protein of canine distemper virus protects dogs from the lethal distemper challenge.
    Wang FX; Zhang SQ; Zhu HW; Yang Y; Sun N; Tan B; Li ZG; Cheng SP; Fu ZF; Wen YJ
    Vet Microbiol; 2014 Dec; 174(3-4):362-371. PubMed ID: 25465178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.